Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clint S Schmidt

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
Peptide antigen priming of naive, but not memory, CD8 T cells requires a third signal that can be provided by IL-12Clint S Schmidt, Matthew F Mescher
Expert Review of Vaccines|June 5, 2007
Smart adjuvantsClint S Schmidt, W John W Morrow, Nadeem A Sheikh
Frontiers in Immunology|October 14, 2014
Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureusMichael R Yeaman, Scott G Filler, Clint S Schmidt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Resistance to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis by death receptor 6-deficient miceClint S Schmidt, Jingyong Zhao, Jana Chain, et al.
Vaccine|October 27, 2012
NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adultsClint S Schmidt, C Jo White, Ashraf S Ibrahim, et al.
Frontiers in Immunology|July 3, 2018
Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal CandidiasisPriya Uppuluri, Shakti Singh, Abdullah Alqarihi, et al.
The Journal of Experimental Medicine|January 8, 2003
Enhanced B cell expansion, survival, and humoral responses by targeting death receptor 6Clint S Schmidt, Jinqi Liu, Tonghai Zhang, et al.
International Immunology|June 17, 2003
LIGHT-deficiency impairs CD8+ T cell expansion, but not effector functionJinqi Liu, Clint S Schmidt, Feisha Zhao, et al.
Vaccine|September 26, 2013
NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune responseAshraf S Ibrahim, Guanpingsheng Luo, Teclegiorgis Gebremariam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivoLisa A E Harmala, Elizabeth G Ingulli, Julie M Curtsinger, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
Peptide antigen priming of naive, but not memory, CD8 T cells requires a third signal that can be provided by IL-12Clint S Schmidt, Matthew F Mescher
Expert Review of Vaccines|June 5, 2007
Smart adjuvantsClint S Schmidt, W John W Morrow, Nadeem A Sheikh
Frontiers in Immunology|October 14, 2014
Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureusMichael R Yeaman, Scott G Filler, Clint S Schmidt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Resistance to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis by death receptor 6-deficient miceClint S Schmidt, Jingyong Zhao, Jana Chain, et al.
Vaccine|October 27, 2012
NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adultsClint S Schmidt, C Jo White, Ashraf S Ibrahim, et al.
Frontiers in Immunology|July 3, 2018
Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal CandidiasisPriya Uppuluri, Shakti Singh, Abdullah Alqarihi, et al.
The Journal of Experimental Medicine|January 8, 2003
Enhanced B cell expansion, survival, and humoral responses by targeting death receptor 6Clint S Schmidt, Jinqi Liu, Tonghai Zhang, et al.
International Immunology|June 17, 2003
LIGHT-deficiency impairs CD8+ T cell expansion, but not effector functionJinqi Liu, Clint S Schmidt, Feisha Zhao, et al.
Vaccine|September 26, 2013
NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune responseAshraf S Ibrahim, Guanpingsheng Luo, Teclegiorgis Gebremariam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivoLisa A E Harmala, Elizabeth G Ingulli, Julie M Curtsinger, et al.
Pageof 2